Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral cysteamine for treatment of cystic fibrosis pulmonary exacerbations in adults
2015-004986-99Phase 2Active
- Sponsor
- NovaBiotics Ltd
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cystic fibrosis-related lung disease comparing Cysteamine bitartrate with Placebo (2 arms). Primary endpoint: Change from baseline in health-related quality of life questionnaires. Started Sep 2016; status: active.
02
Drugs
cysteamine
03
Conditions
cystic fibrosis-related lung disease
Beyond the preview
Go deeper on 2015-004986-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004986-99.